{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:57:03Z","timestamp":1794412623529,"version":"4.9.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1038\/s41574-023-00883-8","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T19:01:44Z","timestamp":1692298904000},"page":"671-678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2508-9588","authenticated-orcid":false,"given":"Ken K. Y.","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula B.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillippe","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0534-8025","authenticated-orcid":false,"given":"Lynnette","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Aghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Raetzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalmon","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9517-338X","authenticated-orcid":false,"given":"Gerald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander D.","family":"Borowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3145-7287","authenticated-orcid":false,"given":"Justo P.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward R.","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8408-7796","authenticated-orcid":false,"given":"Maria Chiara","family":"Zatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Sisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C. J.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9817-9875","authenticated-orcid":false,"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-3447","authenticated-orcid":false,"given":"Shlomo","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"key":"883_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","volume":"43","author":"S Melmed","year":"2022","unstructured":"Melmed, S. et al. Clinical biology of the pituitary adenoma. Endocr. Rev. 43, 1003\u20131037 (2022).","journal-title":"Endocr. Rev."},{"key":"883_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa, S. L., Mete, O., Perry, A. & Osamura, R. Y. Overview of the 2022 WHO classification of pituitary tumors. Endocr. Pathol. 33, 6\u201326 (2022).","journal-title":"Endocr. Pathol."},{"key":"883_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11102-019-00988-2","volume":"22","author":"KKY Ho","year":"2019","unstructured":"Ho, K. K. Y. et al. A tale of pituitary adenomas: to NET or not to NET: pituitary society position statement. Pituitary 22, 569\u2013573 (2019).","journal-title":"Pituitary"},{"key":"883_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1353\/pbm.2011.0015","volume":"54","author":"A Jutel","year":"2011","unstructured":"Jutel, A. Classification, disease, and diagnosis. Perspect. Biol. Med. 54, 189\u2013205 (2011).","journal-title":"Perspect. Biol. Med."},{"key":"883_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1001\/jama.2019.22373","volume":"323","author":"JA Doust","year":"2020","unstructured":"Doust, J. A., Bell, K. J. L. & Glasziou, P. P. Potential consequences of changing disease classifications. JAMA 323, 921\u2013922 (2020).","journal-title":"JAMA"},{"key":"883_CR6","doi-asserted-by":"publisher","first-page":"bvaa205","DOI":"10.1210\/jendso\/bvaa205","volume":"5","author":"K Ho","year":"2021","unstructured":"Ho, K. et al. Pituitary neoplasm nomenclature workshop: does adenoma stand the test of time? J. Endocr. Soc. 5, bvaa205 (2021).","journal-title":"J. Endocr. Soc."},{"key":"883_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11102-022-01235-x","volume":"25","author":"KKY Ho","year":"2022","unstructured":"Ho, K. K. Y., Gadelha, M., Kaiser, U. B., Reincke, M. & Melmed, S. The NETting of pituitary adenoma: a gland illusion. Pituitary 25, 349\u2013351 (2022).","journal-title":"Pituitary"},{"key":"883_CR8","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.21037\/tcr-20-3446","volume":"10","author":"X Liu","year":"2021","unstructured":"Liu, X., Wang, R., Li, M. & Chen, G. Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective. Transl. Cancer Res. 10, 1916\u20131920 (2021).","journal-title":"Transl. Cancer Res."},{"key":"883_CR9","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1001\/jamainternmed.2017.1302","volume":"177","author":"J Doust","year":"2017","unstructured":"Doust, J. et al. Guidance for modifying the definition of diseases: a checklist. JAMA Intern. Med. 177, 1020\u20131025 (2017).","journal-title":"JAMA Intern. Med."},{"key":"883_CR10","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa, S. L. et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an international pituitary pathology club proposal. Endocr. Relat. Cancer 24, C5\u2013C8 (2017).","journal-title":"Endocr. Relat. Cancer"},{"key":"883_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez, A., Karavitaki, N. & Wass, J. A. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. 72, 377\u2013382 (2010).","journal-title":"Clin. Endocrinol."},{"key":"883_CR12","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly, A. F. et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab. 91, 4769\u20134775 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"883_CR13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1530\/EJE-15-0189","volume":"173","author":"TT Agustsson","year":"2015","unstructured":"Agustsson, T. T. et al. The epidemiology of pituitary adenomas in Iceland, 1955-2012: a nationwide population-based study. Eur. J. Endocrinol. 173, 655\u2013664 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"883_CR14","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.mayocp.2022.03.017","volume":"97","author":"CS Graffeo","year":"2022","unstructured":"Graffeo, C. S. et al. Pituitary adenoma incidence, management trends, and long-term outcomes: a 30-year population-based analysis. Mayo Clin. Proc. 97, 1861\u20131871 (2022).","journal-title":"Mayo Clin. Proc."},{"key":"883_CR15","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s11154-020-09556-7","volume":"21","author":"OM Dekkers","year":"2020","unstructured":"Dekkers, O. M., Karavitaki, N. & Pereira, A. M. The epidemiology of aggressive pituitary tumors (and its challenges). Rev. Endocr. Metab. Disord. 21, 209\u2013212 (2020).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"883_CR16","doi-asserted-by":"publisher","first-page":"e1231","DOI":"10.1210\/clinem\/dgab748","volume":"107","author":"AJ Han","year":"2022","unstructured":"Han, A. J., Varlamov, E. V. & Fleseriu, M. Nonfunctioning pituitary microadenomas: should imaging interval be extended? A large single-center cohort study. J. Clin. Endocrinol. Metab. 107, e1231\u2013e1241 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"883_CR17","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1365-2265.2007.02990.x","volume":"67","author":"N Karavitaki","year":"2007","unstructured":"Karavitaki, N. et al. What is the natural history of nonoperated nonfunctioning pituitary adenomas? Clin. Endocrinol. 67, 938\u2013943 (2007).","journal-title":"Clin. Endocrinol."},{"key":"883_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/cen.12879","volume":"84","author":"N Lenders","year":"2016","unstructured":"Lenders, N. et al. Longitudinal evaluation of the natural history of conservatively managed nonfunctioning pituitary adenomas. Clin. Endocrinol. 84, 222\u2013228 (2016).","journal-title":"Clin. Endocrinol."},{"key":"883_CR19","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot, G. et al. European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur. J. Endocrinol. 178, G1\u2013G24 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"883_CR20","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch, M. E. Diagnosis and treatment of pituitary adenomas: a review. JAMA 317, 516\u2013524 (2017).","journal-title":"JAMA"},{"key":"883_CR21","doi-asserted-by":"publisher","first-page":"100510","DOI":"10.1016\/j.lanepe.2022.100510","volume":"23","author":"BE White","year":"2022","unstructured":"White, B. E. et al. Incidence and survival of neuroendocrine neoplasia in England 1995-2018: a retrospective, population-based study. Lancet Reg. Health Eur. 23, 100510 (2022).","journal-title":"Lancet Reg. Health Eur."},{"key":"883_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/cncr.29099","volume":"121","author":"J Hallet","year":"2015","unstructured":"Hallet, J. et al. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer 121, 589\u2013597 (2015).","journal-title":"Cancer"},{"key":"883_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1457496919874484","volume":"110","author":"J Eriksson","year":"2021","unstructured":"Eriksson, J. et al. Primary small intestinal neuroendocrine tumors are highly prevalent and often multiple before metastatic disease develops. Scand. J. Surg. 110, 44\u201350 (2021).","journal-title":"Scand. J. Surg."},{"key":"883_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94658-8","volume":"11","author":"C Chen","year":"2021","unstructured":"Chen, C. et al. Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004-2016. Sci. Rep. 11, 15155 (2021).","journal-title":"Sci. Rep."},{"key":"883_CR25","doi-asserted-by":"publisher","first-page":"E398","DOI":"10.1503\/cmaj.160771","volume":"189","author":"MJ Raphael","year":"2017","unstructured":"Raphael, M. J., Chan, D. L., Law, C. & Singh, S. Principles of diagnosis and management of neuroendocrine tumours. CMAJ 189, E398\u2013E404 (2017).","journal-title":"CMAJ"},{"key":"883_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000443165","volume":"103","author":"UF Pape","year":"2016","unstructured":"Pape, U. F. et al. ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas). Neuroendocrinology 103, 144\u2013152 (2016).","journal-title":"Neuroendocrinology"},{"key":"883_CR27","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari, A. et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 3, 1335\u20131342 (2017).","journal-title":"JAMA Oncol."},{"key":"883_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ydbio.2004.03.013","volume":"270","author":"SE Schonhoff","year":"2004","unstructured":"Schonhoff, S. E., Giel-Moloney, M. & Leiter, A. B. Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. Dev. Biol. 270, 443\u2013454 (2004).","journal-title":"Dev. Biol."},{"key":"883_CR29","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1093\/emboj\/cdf649","volume":"21","author":"M Jenny","year":"2002","unstructured":"Jenny, M. et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 21, 6338\u20136347 (2002).","journal-title":"EMBO J."},{"key":"883_CR30","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1073\/pnas.97.4.1607","volume":"97","author":"G Gradwohl","year":"2000","unstructured":"Gradwohl, G., Dierich, A., LeMeur, M. & Guillemot, F. neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc. Natl Acad. Sci. USA 97, 1607\u20131611 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"883_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/JME-18-0090","volume":"61","author":"M Ando","year":"2018","unstructured":"Ando, M. et al. The proneural bHLH genes Mash1, Math3 and NeuroD are required for pituitary development. J. Mol. Endocrinol. 61, 127\u2013138 (2018).","journal-title":"J. Mol. Endocrinol."},{"key":"883_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2009.12.012","volume":"323","author":"SW Davis","year":"2010","unstructured":"Davis, S. W. et al. Molecular mechanisms of pituitary organogenesis: in search of novel regulatory genes. Mol. Cell Endocrinol. 323, 4\u201319 (2010).","journal-title":"Mol. Cell Endocrinol."},{"key":"883_CR33","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1210\/er.2016-1101","volume":"37","author":"Q Fang","year":"2016","unstructured":"Fang, Q. et al. Genetics of combined pituitary hormone deficiency: roadmap into the genome era. Endocr. Rev. 37, 636\u2013675 (2016).","journal-title":"Endocr. Rev."},{"key":"883_CR34","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi, G. et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod. Pathol. 31, 1770\u20131786 (2018).","journal-title":"Mod. Pathol."},{"key":"883_CR35","unstructured":"Brown, M. B. & Limaiem, F. Histology, parathyroid gland. StatPearls https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546596\/ (2022)."},{"key":"883_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","volume":"33","author":"G Rindi","year":"2022","unstructured":"Rindi, G. et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr. Pathol. 33, 115\u2013154 (2022).","journal-title":"Endocr. Pathol."},{"key":"883_CR37","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1385\/EP:12:3:291","volume":"12","author":"F Satoh","year":"2001","unstructured":"Satoh, F., Umemura, S., Yasuda, M. & Osamura, R. Y. Neuroendocrine marker expression in thyroid epithelial tumors. Endocr. Pathol. 12, 291\u2013299 (2001).","journal-title":"Endocr. Pathol."},{"key":"883_CR38","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/1097-0142(19950201)75:3<860::AID-CNCR2820750318>3.0.CO;2-G","volume":"75","author":"HR Haak","year":"1995","unstructured":"Haak, H. R. & Fleuren, G. J. Neuroendocrine differentiation of adrenocortical tumors. Cancer 75, 860\u2013864 (1995).","journal-title":"Cancer"},{"key":"883_CR39","doi-asserted-by":"publisher","first-page":"111726","DOI":"10.1016\/j.mce.2022.111726","volume":"555","author":"R Uhlig","year":"2022","unstructured":"Uhlig, R. et al. Synaptophysin and chromogranin A expression analysis in human tumors. Mol. Cell Endocrinol. 555, 111726 (2022).","journal-title":"Mol. Cell Endocrinol."},{"key":"883_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas, J. et al. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol. 126, 123\u2013135 (2013).","journal-title":"Acta Neuropathol."},{"key":"883_CR41","first-page":"610","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp, E., Steiner, E., Kitz, K. & Matula, C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33, 610\u2013617 (1993).","journal-title":"Neurosurgery"},{"key":"883_CR42","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","volume":"102","author":"G Raverot","year":"2017","unstructured":"Raverot, G. et al. Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J. Clin. Endocrinol. Metab. 102, 3368\u20133374 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"883_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1530\/EJE-22-0812","volume":"187","author":"N Sahakian","year":"2022","unstructured":"Sahakian, N. et al. Real-life clinical impact of a five-tiered classification of pituitary tumors. Eur. J. Endocrinol. 187, 893\u2013904 (2022).","journal-title":"Eur. J. Endocrinol."},{"key":"883_CR44","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/EJE-18-0749","volume":"180","author":"S Asioli","year":"2019","unstructured":"Asioli, S. et al. Validation of a clinicopathological score for the prediction of post-surgical evolution of pituitary adenoma: retrospective analysis on 566 patients from a tertiary care centre. Eur. J. Endocrinol. 180, 127\u2013134 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"883_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000514862","volume":"112","author":"A Spada","year":"2022","unstructured":"Spada, A. et al. Pituitary tumors: genetic and molecular factors underlying pathogenesis and clinical behavior. Neuroendocrinology 112, 15\u201333 (2022).","journal-title":"Neuroendocrinology"},{"key":"883_CR46","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.3390\/cancers13194857","volume":"13","author":"LE Wildemberg","year":"2021","unstructured":"Wildemberg, L. E. et al. gsp mutation is not a molecular biomarker of long-term response to first-generation somatostatin receptor ligands in acromegaly. Cancers 13, 4857 (2021).","journal-title":"Cancers"},{"key":"883_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke, M. et al. Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat. Genet. 47, 31\u201338 (2015).","journal-title":"Nat. Genet."},{"key":"883_CR48","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1210\/clinem\/dgaa749","volume":"106","author":"O Casar-Borota","year":"2021","unstructured":"Casar-Borota, O. et al. Corticotroph aggressive pituitary tumors and carcinomas frequently harbor ATRX mutations. J. Clin. Endocrinol. Metab. 106, 1183\u20131194 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"883_CR49","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00428-006-0250-1","volume":"449","author":"G Rindi","year":"2006","unstructured":"Rindi, G. et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 449, 395\u2013401 (2006).","journal-title":"Virchows Arch."},{"key":"883_CR50","doi-asserted-by":"publisher","first-page":"101290","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson, P. & Maiter, D. The epidemiology, diagnosis and treatment of Prolactinomas: The old and the new. Best Pract. Res. Clin. Endocrinol. Metab. 33, 101290 (2019).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"883_CR51","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","volume":"9","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu, M. et al. Consensus on diagnosis and management of Cushing\u2019s disease: a guideline update. Lancet Diabetes Endocrinol. 9, 847\u2013875 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"883_CR52","doi-asserted-by":"publisher","first-page":"R375","DOI":"10.1530\/ERC-20-0136","volume":"27","author":"MP Yavropoulou","year":"2020","unstructured":"Yavropoulou, M. P., Tsoli, M., Barkas, K., Kaltsas, G. & Grossman, A. The natural history and treatment of non-functioning pituitary adenomas (non-functioning PitNETs). Endocr. Relat. Cancer 27, R375\u2013R390 (2020).","journal-title":"Endocr. Relat. Cancer"},{"key":"883_CR53","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamaoncol.2019.0054","volume":"5","author":"PR Dixon","year":"2019","unstructured":"Dixon, P. R. et al. The role of disease label in patient perceptions and treatment decisions in the setting of low-risk malignant neoplasms. JAMA Oncol. 5, 817\u2013823 (2019).","journal-title":"JAMA Oncol."},{"key":"883_CR54","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1017\/S0022215105004688","volume":"120","author":"NK Chadha","year":"2006","unstructured":"Chadha, N. K. & Repanos, C. Patients\u2019 understanding of words used to describe lumps: a cross-sectional study. J. Laryngol. Otol. 120, 125\u2013128 (2006).","journal-title":"J. Laryngol. Otol."},{"key":"883_CR55","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/fampra\/cmv008","volume":"32","author":"A Van den Bruel","year":"2015","unstructured":"Van den Bruel, A. The triumph of medicine: how overdiagnosis is turning healthy people into patients. Fam. Pract. 32, 127\u2013128 (2015).","journal-title":"Fam. Pract."},{"key":"883_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5694\/mja2.50455","volume":"212","author":"PP Glasziou","year":"2020","unstructured":"Glasziou, P. P., Jones, M. A., Pathirana, T., Barratt, A. L. & Bell, K. J. Estimating the magnitude of cancer overdiagnosis in Australia. Med. J. Aust. 212, 163\u2013168 (2020).","journal-title":"Med. J. Aust."},{"key":"883_CR57","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","volume":"15","author":"LJ Esserman","year":"2014","unstructured":"Esserman, L. J. et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 15, e234\u2013e242 (2014).","journal-title":"Lancet Oncol."},{"key":"883_CR58","doi-asserted-by":"publisher","first-page":"k4699","DOI":"10.1136\/bmj.k4699","volume":"364","author":"LJ Esserman","year":"2019","unstructured":"Esserman, L. J. & Varma, M. Should we rename low risk cancers? BMJ 364, k4699 (2019).","journal-title":"BMJ"},{"key":"883_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/MOU.0000000000000945","volume":"32","author":"JI Epstein","year":"2022","unstructured":"Epstein, J. I. Is grade group 1 (Gleason score 3 + 3 = 6) adenocarcinoma of the prostate really cancer? Curr. Opin. Urol. 32, 91\u201395 (2022).","journal-title":"Curr. Opin. Urol."},{"key":"883_CR60","doi-asserted-by":"publisher","first-page":"461","DOI":"10.5858\/arpa.2020-0015-RA","volume":"145","author":"JI Epstein","year":"2021","unstructured":"Epstein, J. I. et al. The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer. Arch. Pathol. Lab. Med. 145, 461\u2013493 (2021).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"883_CR61","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed, S. Pituitary-tumor endocrinopathies. N. Engl. J. Med. 382, 937\u2013950 (2020).","journal-title":"N. Engl. J. Med."},{"key":"883_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou, M. et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37, 123\u2013134 e125 (2020).","journal-title":"Cancer Cell"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00883-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00883-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00883-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T13:03:59Z","timestamp":1697029439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00883-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":62,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1038\/s41574-023-00883-8","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"21 July 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}